US Broker Ratings

ResMed Inc. (RMD) Stock Analysis: Unveiling a 16.64% Potential Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $30.74 billion, this San Diego-based..

Bruker Corporation (BRKR) Stock Analysis: Unveiling a 10% Upside Potential in the Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, is firmly positioned within the medical devices industry, offering a compelling narrative for investors seeking exposure to cutting-edge scientific..

AstraZeneca PLC (AZN) Stock Analysis: Unveiling a 32% Potential Upside Amid Strong Buy Ratings

AstraZeneca PLC (AZN), a leading biopharmaceutical titan based in Cambridge, UK, is making waves in the healthcare sector with its robust pipeline of prescription medicines. With a market capitalization of..

Corcept Therapeutics (CORT) Stock Report: A Potential 22% Upside Amid Robust Revenue Growth

Corcept Therapeutics Incorporated (CORT) presents a compelling investment opportunity in the biotechnology sector, particularly for those keen on high-growth potential. With a market capitalization of $11.97 billion, this Redwood City-based..

Edwards Lifesciences Corporation (EW) Stock Analysis: Strong Buy Ratings Signal 12.53% Upside Potential

Edwards Lifesciences Corporation (NYSE: EW) stands as a prominent player in the healthcare sector, specifically within the medical devices industry. With a substantial market capitalization of $51.66 billion, the company..

Chemed Corp (CHE) Stock Analysis: Navigating High Valuation with Sustainable Growth Potential

Chemed Corp (NYSE: CHE), a stalwart in the healthcare sector, has carved out a niche in the medical care facilities industry. With a market capitalization of $7.22 billion, Chemed is..

Moderna, Inc. (MRNA) Stock Analysis: Navigating Potential Amidst a -14.07% Downside

Moderna, Inc. (NASDAQ: MRNA) has become a household name in the biotechnology sector, particularly due to its mRNA technology that revolutionized vaccine development during the COVID-19 pandemic. As the company..

BeOne Medicines Ltd. (ONC) Stock Analysis: 23.95% Potential Upside Captures Investor Attention

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology industry, is generating significant buzz among investors. With a market capitalization of $39.4 billion and a robust pipeline of oncology..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: A 30% Upside Potential with Strong Buy Ratings

Neurocrine Biosciences, Inc. (NBIX), a leading player in the healthcare sector, is increasingly capturing the attention of investors with its robust growth metrics and promising pipeline. Specializing in the development..

Cigna Group (CI) Stock Analysis: Unpacking the 20.86% Potential Upside for Investors

For investors eyeing opportunities in the healthcare sector, The Cigna Group (NYSE: CI) presents a compelling case with a potential upside of 20.86%. As a major player in the healthcare..

Repligen Corporation (RGEN) Stock Analysis: A Healthcare Standout with 13.3% Potential Upside

Repligen Corporation (NASDAQ: RGEN) is a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Waltham, Massachusetts, the company has carved out a..

Legend Biotech Corporation (LEGN) Stock Analysis: 151% Potential Upside Sparks Investor Interest

Legend Biotech Corporation (NASDAQ: LEGN) is capturing the attention of investors with its impressive potential upside of 151.08%. As a key player in the biotechnology sector, Legend Biotech is making..

Bio-Techne Corp (TECH) Stock Analysis: Navigating an 11 Billion Dollar Market Cap Amid Modest Growth Challenges

Bio-Techne Corp (NASDAQ: TECH), a prominent player in the biotechnology sector, is capturing significant attention from investors due to its robust market capitalization of $11.26 billion. Specializing in life science..

Grifols, S.A. (GRFS) Stock Analysis: Unpacking the 36.84% Potential Upside for Investors

Investors looking for opportunities in the healthcare sector might find Grifols, S.A. (NASDAQ: GRFS) an intriguing prospect. With a robust presence in the plasma-derived medicines market, this Spanish company is..

Penumbra, Inc. (PEN) Stock Analysis: Evaluating the 11.45% Potential Upside in Medical Devices

As investors continuously seek out promising opportunities in the healthcare sector, Penumbra, Inc. (NYSE: PEN) emerges as a noteworthy player within the medical devices industry. With a market capitalization of..

Illumina, Inc. (ILMN) Stock Analysis: Navigating Potential Upside in Genomic Innovation

For investors with a keen eye on the healthcare sector, Illumina, Inc. (NASDAQ: ILMN) presents a compelling narrative of innovation-driven growth. As a leader in the diagnostics and research industry,..

Doximity, Inc. (DOCS) Stock Analysis: Navigating a 7.34% Potential Upside in the Healthcare Sector

Doximity, Inc. (DOCS) stands as a compelling player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $4.88 billion, the company operates a..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: A 14.95% Upside with Strong Buy Ratings

GE HealthCare Technologies Inc. (NYSE: GEHC) is making waves in the healthcare sector with its robust performance and promising growth potential. As a key player in the medical devices industry,..

Ascendis Pharma A/S (ASND) Stock Analysis: Unpacking a Promising 20% Upside Potential

Investors looking to tap into the burgeoning biotechnology sector should not overlook Ascendis Pharma A/S (NASDAQ: ASND), a dynamic player in the healthcare industry based in Hellerup, Denmark. With a..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a 103% Potential Upside in the Biotech Sector

Summit Therapeutics Inc. (NASDAQ: SMMT), a biotechnology company with a market capitalization of $11.14 billion, is capturing investor attention with its promising pipeline and significant potential upside. Operating within the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds